Aggiornamento
Le neutropenie del neonato
Neonatal neutropoenias
Piero Farruggia
Oncoematologia Pediatrica, ARNAS Civico, Palermo
Febbraio 2017 - pagg. 85 -90
Abstract
Neonatal neutropoenia is not infrequent. Its appearance can be linked to many serious
or minor causes and it is necessary to provide an accurate overview in order to make
the best decisions on its management. This paper takes into consideration some possible
phenomena causing the appearance of neutropoenia in newborns; some of them are little
known either by paediatricians or neonatologists. It also provides guidance for possible
differential diagnostic criteria as well as information about the therapy, which today
often employs the use of Granulocyte-Colony Stimulating Factor (G-CSF).
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Dinauer MC. The phagocyte system and disorders
of granulopoiesis and granulocyte
function. In: Nathan DG, Orkin SH (Eds).
Nathan and Oshi’s hematology of infancy and
childhood. Philadelphia: WBS Saunders Company,
2003:923-1010.
2. Schmutz N, Henry E, Jopling J, et al. Expected
ranges for blood neutrophil concentrations
of neonates: the Manroe and Mouzinho
charts revisited. J Perinatol 2008;28:
275-81.
3. Wirbelauer J, Thomas W, Rieger L, et al. Intrauterine
growth retardation in preterm infants
≤ 32 weeks of gestation is associated with
low white blood cell counts. Am J Perinatol
2010;2:819-24.
4. Christensen RD, Yoder BA, Baer VL, Snow
GL, Butler A. Early-onset neutropenia in
small-for-gestational-age infants. Pediatrics
2015;136(5):e1259-67.
5. Farruggia P. Immune neutropenias of infancy
and childhood. World J Pediatr 2016;12:
142-8.
6. Porretti L, Cattaneo A, Coluccio E, et al. Implementation
and outcomes of a transfusionrelated
acute lung injury surveillance programme
and study of HLA/HNA alloimmunisation
in blood donors. Blood Transfus 2012;
10:351-9.
7. Hauck B, Philipp A, Eckstein R, et al. Human
neutrophil alloantigen genotype frequencies
among blood donors with Turkish and
German descent. Tissue Antigens 2011;78:
416-20.
8. Steffensen R, Gülen T, Varming K, et al. FcgammaRIIIB
polymorphism: evidence that
NA1/NA2 and SH are located in two closely
linked loci and that the SH allele is linked to
the NA1 allele in the Danish population. Transfusion
1999;39:593-8.
9. Fung YL, Pitcher LA, Taylor K, et al. Managing
passively acquired autoimmune neonatal
neutropenia: a case study. Transfus Med 2005;
15:151-5.
10. Davoren A, Saving K, McFarland JG, et al.
Neonatal neutropenia and bacterial sepsis associated
with placental transfer of maternal
neutrophil-specific autoantibodies. Transfusion 2004;44:1041-6.
11. Kameoka J, Funato T, Miura T, et al. Autoimmune
neutropenia in pregnant women
causing neonatal neutropenia. Br J Haematol
2001;114:198-200.
12. van Leeuwen EF, Roord JJ, de Gast GC,
Vander Plas-Van Dalen C. Neonatal neutropenia
due to maternal autoantibodies against
neutrophils. Br Med J (Clin Res Ed) 1983;287
(6385):94.
13. Curtis BR, Reno C, Aster RH. Neonatal alloimmune
neutropenia attributed to maternal
immunoglobulin G antibodies against the neutrophil
alloantigen HNA-1c (SH): a report of
five cases. Transfusion 2005;45:1308-13.
14. Hessner MJ, Shivaram SM, Dinauer DM,
Curtis BR, Endean DJ, Aster RH. Neutrophil
antigen (FcgammaRIIIB) SH gene frequencies
in six racial groups. Blood 1999;93(3):
1115-6.
15. Norcia AM, Sugano EY, Chiba AK, et al.
Human neutrophil alloantigen-1a, -1b, -2, -3a
and -4a frequencies in Brazilians. Tissue Antigens
2009;74(5):404-7.
16. Lopes LB, Baleotti W Jr, Suzuki RB, et al.
HNA-3 gene frequencies in Brazilians and a
new polymerase chain reaction-restriction
fragment length polymorphism method for
HNA-3a/3b genotyping. Transfusion 2014;54
(6):1619-21.
17. Kissel K, Hofmann C, Gittinger FS,
Daniels G, Bux J. HNA-1a, HNA-1b, and HNA-
1c (NA1, NA2, SH) frequencies in African and
American Blacks and in Chinese. Tissue Antigens
2000;56(2):143-8.
18. Verheugt FW, von dem Borne AE, van
Noord-Bokhorst JC, Engelfriet CP. Autoimmune
granulocytopenia: the detection of granulocyte
autoantibodies with the immunofluorescence
test. Br J Haematol 1978;39(3): 339-50.
19. Badolato R, Fontana S, Notarangelo LD,
Savoldi G. Congenital neutropenia: advances
in diagnosis and treatment. Curr Opin Allergy
Clin Immunol 2004;4(6):513-21.
20. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis
and clinical course of autoimmune neutropenia
in infancy: analysis of 240 cases.
Blood 1998;91(1):181-6.
21. Farruggia P, Fioredda F, Puccio G, et al.
Autoimmune neutropenia of infancy: Data
from the Italian Neutropenia Registry. Am J
Hematol 2015;90(12):E221-2.
22. Fioredda F, Calvillo M, Burlando O, et al.
Infectious complications in children with severe
congenital, autoimmune or idiopathic
neutropenia: a retrospective study from the
Italian Neutropenia Registry. Pediatr Infect
Dis J 2013;32(4):410-2.
23. Fromont P, Bettaieb A, Skouri H, et al. Frequency
of the polymorphonuclear neutrophil
Fc gamma receptor III deficiency in the
French population and its involvement in the
development of neonatal alloimmune neutropenia.
Blood 1992;79(8):2131-4.
24. Zupańska B, Uhrynowska M, Guz K, et al.
The risk of antibody formation against HNA1a
and HNA1b granulocyte antigens during pregnancy
and its relation to neonatal neutropenia.
Transfus Med 2001;11(5):377-82.
25. Bux J, Jung KD, Kauth T, Mueller-
Eckhardt C. Serological and clinical aspects of
granulocyte antibodies leading to alloimmune
neonatal neutropenia. Transfus Med
1992;2(2):143-9.
26. Williams BA, Fung YL. Alloimmune neonatal
neutropenia: can we afford the consequences
of a missed diagnosis? J Paediatr
Child Health 2006;42(1-2):59-61.
27. Tomicic M, Starcevic M, Ribicic R, Golubic-
Cepulic B, Hundric-Haspl Z, Jukic I. Alloimmune
neonatal neutropenia in Croatia during
the 1998-2008 period. Am J Reprod Immunol
2014;71(5):451-7.
28. van den Tooren-de Groot R, Ottink M, Huiskes
E, et al. Management and outcome of 35
cases with foetal/neonatal alloimmune neutropenia.
Acta Paediatr 2014;103(11):e467-74.
29. Curtis BR, Reno C, Aster RH. Neonatal alloimmune
neutropenia attributed to maternal
immunoglobulin G antibodies against the neutrophil
alloantigen HNA-1c (SH): a report of
five cases. Transfusion 2005;45(8):1308-13.
30. Rodwell RL, Gray PH, Taylor KM, Minchinton
R. Granulocyte colony stimulating factor
treatment for alloimmune neonatal neutropenia.
Arch Dis Child Fetal Neonatal Ed
1996;75(1):F57-8.
31. Desenfants A, Jeziorski E, Plan O, et al. Intravenous
immunoglobulins for neonatal alloimmune
neutropenia refractory to recombinant
human granulocyte colony-stimulating
factor. Am J Perinatol 2011;28(6):461-6.
32. Bedu A, Baumann C, Rohrlich P, Duval M,
Fenneteau O, Cartron J. Failure of granulocyte
colony-stimulating factor in alloimmune
neonatal neutropenia. J Pediatr 1995;127(3):
508-9.
33. Maheshwari A, Christensen RD, Calhoun
DA. Resistance to recombinant human granulocyte
colony-stimulating factor in neonatal alloimmune
neutropenia associated with antihuman
neutrophil antigen-2a (NB1) antibodies.
Pediatrics 2002;109(4):e64.
34. Fung YL, Pitcher LA, Taylor K,
Minchinton RM. Managing passively acquired
autoimmune neonatal neutropenia: a case
study. Transfus Med 2005;15(2):151-5.
35. Davoren A, Saving K, McFarland JG, Aster
RH, Curtis BR. Neonatal neutropenia and bacterial
sepsis associated with placental transfer
of maternal neutrophil-specific autoantibodies.
Transfusion 2004;44(7):1041-6.
36. Kameoka J, Funato T, Miura T, et al. Autoimmune
neutropenia in pregnant women
causing neonatal neutropenia. Br J Haematol
2001;114(1):198-200.
37. Capsoni F, Sarzi-Puttini P, Zanella A. Primary
and secondary autoimmune neutropenia.
Arthritis Res Ther 2005;7(5):208-14.
38. Zeidler C, Grote UA, Nickel A, et al. Outcome
and management of pregnancies in severe
chronic neutropenia patients by the European
Branch of the Severe Chronic Neutropenia
International Registry. Haematologica
2014;99(8):1395-402.
39. Maheshwari A. Neutropenia in the newborn.
Curr Opin Hematol 2014;21(1):43-9.
40. Benitz WE. Adjunct laboratory tests in the
diagnosis of early-onset neonatal sepsis. Clin
Perinatol 2010;37(2):421-38.
41. Hornik CP, Benjamin DK, Becker KC, et
al. Use of the complete blood cell count in late-
onset neonatal sepsis. Pediatr Infect Dis J
2012;31(8):803-7.
42. Newman TB, Draper D, Puopolo KM, Wi
S, Escobar GJ. Combining immature and total
neutrophil counts to predict early onset sepsis
in term and late preterm newborns: use of the
I/T2. Pediatr Infect Dis J 2014;33(8):798-802.
43. Del Vecchio A, Christensen RD. Neonatal
neutropenia: what diagnostic evaluation is
needed and when is treatment recommended?
Early Hum Dev 2012;88 Suppl 2:S19-24.
44. Chaudhuri J, Mitra S, Mukhopadhyay D,
Chakraborty S, Chatterjee S. Granulocyte Colony-
stimulating Factor for Preterms with Sepsis
and Neutropenia: a Randomized Controlled
Trial. J Clin Neonatol 2012;1(4):202-6.
45. Farruggia P, Dufour C. Diagnosis and management
of primary autoimmune neutropenia
in children: insights for clinicians. Ther
Adv Hematol 2015;6(1):15-24.
46. Engle WD, Rosenfeld CR. Neutropenia in
high-risk neonates. J Pediatr 1984;10586:982-
6.
47. Koenig JM, Christensen RD. Neutropenia
and thrombocytopenia in infants with Rh hemolytic
disease. J Pediatr 1989;114(4 Pt 1):
625-31.
48. Blanco E, Johnston DL. Neutropenia in infants
with hemolytic disease of the newborn.
Pediatr Blood Cancer 2012;5886):950-2.
49. Koenig JM, Hunter DD, Christensen RD.
Neutropenia in donor (anemic) twins involved
in the twin-twin transfusion syndrome. J Perinatol
1991;11(4):355-8.
50. Rovira N, Noguera-Julian A, Rives S, Berrueco
R, Lahoz R, Fortuny C. Influence of new
antiretrovirals on hematological toxicity in
HIV-exposed uninfected infants. Eur J Pediatr
2016;175(7):1013-7.
51. Fioredda F, Calvillo M, Bonanomi S, et al.
Congenital and acquired neutropenia consensus
guidelines on diagnosis from the Neutropenia
Committee of the Marrow Failure Syndrome
Group of the AIEOP (Associazione Italiana
Emato-Oncologia Pediatrica). Pediatr
Blood Cancer 2011;57(1):10-7.
52. Skokowa J, Steinemann D, Katsman-Kuipers
JE, et al. Cooperativity of RUNX1 and
CSF3R mutations in severe congenital neutropenia:
a unique pathway in myeloid leukemogenesis.
Blood 2014;123:2229-37.
53. Farruggia P, Di Cataldo A, Pinto RM, et al.
Pearson Syndrome: a Retrospective Cohort
Study from the Marrow Failure Study Group
of AIEOP (Associazione Italiana Emato-Oncologia
Pediatrica). JIMD Rep 2016;26:37-43.
Corrispondenza: piero.farruggia@arnascivico.it
